The DOI matches its Crossref record; 389 of the 389 references it cites were found in a registry or an index.
Platelets and cancer: a casual or causal relationship: revisited
Open accessAbstract
Human platelets arise as subcellular fragments of megakaryocytes in bone marrow. The physiologic demand, presence of disease such as cancer, or drug effects can regulate the production circulating platelets. Platelet biology is essential to hemostasis, vascular integrity, angiogenesis, inflammation, innate immunity, wound healing, and cancer biology. The most critical biological platelet response is serving as “First Responders” during the wounding process. The exposure of extracellular matrix proteins and intracellular components occurs after wounding. Numerous platelet receptors recognize matrix proteins that trigger platelet activation, adhesion, aggregation, and stabilization. Once activated, platelets change shape and degranulate to release growth factors and bioactive lipids into the blood stream. This cyclic process recruits and aggregates platelets along with thrombogenesis. This process facilitates wound closure or can recognize circulating pathologic bodies. Cancer cell entry into the blood stream triggers platelet-mediated recognition and is amplified by cell surface receptors, cellular products, extracellular factors, and immune cells. In some cases, these interactions suppress immune recognition and elimination of cancer cells or promote arrest at the endothelium, or entrapment in the microvasculature, and survival. This supports survival and spread of cancer cells and the establishment of secondary lesions to serve as important targets for prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,908
Ridley, A. J., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90163-7 · Cited by 4,468
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,652
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Hamberg, M., Svensson, J., & Samuelsson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,045
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600 · cited 1×
“The spatial separation of these niches effectively establishes a decreasing oxygen gradient [86, 87], as well as microenvironmental gradients of cytokines and chemokines, growth factors, and calcium in the osteoblastic niche.”
BackgroundTumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
de Rooij, J., Zwartkruis, F. J. T., Verheijen, M. H. G., Cool, R. H., Nijman, S. M. B., Wittinghofer, A., & Bos, J. L. (1998) · Nature · doi:10.1038/24884 · Cited by 1,969
Endothelial and perivascular cells maintain haematopoietic stem cells
Ding, L., Saunders, T. L., Enikolopov, G., & Morrison, S. J. (2012) · Nature · doi:10.1038/nature10783 · Cited by 1,954
The Journal of Laboratory and Clinical Medicine
(2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00127-6 · Cited by 1,767
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Contribution of platelets to tumour metastasis
Gay, L. J., & Felding-Habermann, B. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3004 · Cited by 1,645
A Light and Electron Microscopic Study
Schochet, S. S., McCermick, W. F., & F, G. F. (1976) · Cited by 1,642
(1956) · Observations on the Alewife, Pomolobus Pseudoharengus (Wilson), in Fresh Wate · doi:10.3138/9781487596026-005 · Cited by 1,534
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
NEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L. T., Schmittgen, T. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003694 · Cited by 1,452
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human Platelets
Hamberg, M., & Samuelsson, B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.9.3400 · Cited by 1,407
Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells
Zwaal, R. F. A., & Schroit, A. J. (1997) · Blood · doi:10.1182/blood.v89.4.1121 · Cited by 1,340
Prostaglandins and Thromboxanes
Samuelsson, B., Goldyne, M., Granström, E., Hamberg, M., Hammarström, S., & Malmsten, C. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.005025 · Cited by 1,299
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
de Sauvage, F. J., Hass, P. E., Spencer, S. D., Malloy, B. E., Gurney, A. L., Spencer, S. A., Darbonne, W. C., Henzel, W. J., Wong, S. C., Kuang, W.-J., et al. (1994) · Nature · doi:10.1038/369533a0 · Cited by 1,263
Epidemiology of cancer-associated venous thrombosis
Timp, J. F., Braekkan, S. K., Versteeg, H. H., & Cannegieter, S. C. (2013) · Blood · doi:10.1182/blood-2013-04-460121 · Cited by 1,205
The journal of clinical investigation
(1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92394-9 · Cited by 1,198
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,169
Platelet α-granules: Basic biology and clinical correlates
Blair, P., & Flaumenhaft, R. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.04.001 · Cited by 1,157
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · cited 1×
“It can reduce platelet aggregation and adhesion in addition to reducing hypercoagulability [246].”
BackgroundStructure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Solomon, S. D., Kim, K., Tang, J., Rosenstein, R. B., Wittes, J., Corle, D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061355 · Cited by 1,048
4 Histology and Histopathology
(2015) · Burghardt’s Colposcopy and Cervical Pathology · doi:10.1055/b-0035-108581 · Cited by 1,043
(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/45.4.773 · Cited by 1,025
Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation
Hamberg, M., Svensson, J., Wakabayashi, T., & Samuelsson, B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.2.345 · Cited by 989
Celecoxib for the Prevention of Colorectal Adenomatous Polyps
Arber, N., Eagle, C. J., Spicak, J., Rácz, I., Dite, P., Hajer, J., Zavoral, M., Lechuga, M. J., Gerletti, P., Tang, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061652 · Cited by 975
Ridley, A. J. (2011) · Cell · doi:10.1016/j.cell.2011.06.010 · Cited by 956
Bunting, S., Moncada, S., Vane, J. R., & Gryglewski, R. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90125-8 · Cited by 950
Bartley, T. (1994) · Cell · doi:10.1016/0092-8674(94)90450-2 · Cited by 940
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Stenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V., & Bainton, D. F. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.880 · Cited by 871
The incredible journey: From megakaryocyte development to platelet formation
Machlus, K. R., & Italiano, J. E. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201304054 · Cited by 856
Trousseau's syndrome: multiple definitions and multiple mechanisms
Varki, A. (2007) · Blood · doi:10.1182/blood-2006-10-053736 · Cited by 840
Tumor heterogeneity and the biology of cancer invasion and metastasis.
Fidler, I. J. (1978) · PubMed · Cited by 818
Paraneoplastic thrombocytosis in ovarian cancer
Stone, R. L., Nick, A. M., McNeish, I. A., Balkwill, F., Han, H. D., Bottsford-Miller, J., Rupaimoole, R., Armaiz-Pena, G. N., Pecot, C. V., Coward, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110352 · Cited by 812
Self-citationThe complex transcriptional landscape of the anucleate human platelet
Bray, P. F., McKenzie, S. E., Edelstein, L. C., Nagalla, S., Delgrosso, K., Ertel, A., Kupper, J., Jing, Y., Londin, E., Loher, P., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-1 · Cited by 802
Platelets, inflammation and tissue regeneration
Nurden, A. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0720 · Cited by 791
Johnston, G. I., Cook, R. G., & McEver, R. P. (1989) · Cell · doi:10.1016/0092-8674(89)90636-3 · Cited by 786
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Trends in Cell Biology · doi:10.1016/0962-8924(92)90174-l · Cited by 755
Antimetastatic effects associated with platelet reduction.
Gasic, G. J., Gasic, T. B., & Stewart, C. C. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.61.1.46 · Cited by 720
Cuzick, J., Otto, F., Baron, J. A., Brown, P. H., Burn, J., Greenwald, P., Jankowski, J., La Vecchia, C., Meyskens, F., Senn, H. J., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70035-x · Cited by 714
WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac
Miki, H., Suetsugu, S., & Takenawa, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6932 · Cited by 709
(2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00347-3 · Cited by 705
Foxall, C., Watson, Sr., Dowbenko, D., Fennie, C., Lasky, L., Kiso, M., Hasegawa, A., Asa, D., & Brandley, B. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.4.895 · Cited by 687
Dynamic Visualization of Thrombopoiesis Within Bone Marrow
Junt, T., Schulze, H., Chen, Z., Massberg, S., Goerge, T., Krueger, A., Wagner, D. D., Graf, T., Italiano, J. E., Shivdasani, R. A., et al. (2007) · Science · doi:10.1126/science.1146304 · Cited by 652
c-Mpl ligand is a humoral regulator of megakaryocytopoiesis
Wendling, F., Maraskovsky, E., Debili, N., Florindo, C., Teepe, M., Titeux, M., Methia, N., Breton-Gorius, J., Cosman, D., & Vainchenker, W. (1994) · Nature · doi:10.1038/369571a0 · Cited by 643
Mellion, B., Ignarro, L., Ohlstein, E., Pontecorvo, E., Hyman, A., & Kadowitz, P. (1981) · Blood · doi:10.1182/blood.v57.5.946.946 · Cited by 639
Trousseau, A. (1865) · Medical Entomology and Zoology · Cited by 635
Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.
Weksler, B. B., Marcus, A. J., & Jaffe, E. A. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3922 · Cited by 620
Uncertainty in the niches that maintain haematopoietic stem cells
Kiel, M. J., & Morrison, S. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2279 · Cited by 589
Integrin activation controls metastasis in human breast cancer
Felding-Habermann, B., O'Toole, T. E., Smith, J. W., Fransvea, E., Ruggeri, Z. M., Ginsberg, M. H., Hughes, P. E., Pampori, N., Shattil, S. J., Saven, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1853 · Cited by 577
Picker, L. J., Warnock, R. A., Burns, A. R., Doerschuk, C. M., Berg, E. L., & Butchert, E. C. (1991) · Cell · doi:10.1016/0092-8674(91)90438-5 · Cited by 570
Journal of Biological Regulators and Homeostatic Agents
Bolognesi, A. (2006) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · Cited by 548
Díaz‐Flores, L., Gutiérrez, R., Madrid, J. F., Varela, H., Valladares, F., Acosta, E., Martı́n-Vasallo, P., & Díaz-Flores, L. (2009) · PubMed · doi:10.14670/hh-24.909 · Cited by 545
Progress in Clinical and Biological Research
Rumsby, M. G. (1984) · Neurochemistry International · doi:10.1016/0197-0186(84)90053-6 · Cited by 534
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2
Suzuki-Inoue, K. (2006) · Blood · doi:10.1182/blood-2005-05-1994 · Cited by 523
Egile, C., Loisel, T. P., Laurent, V., Li, R., Pantaloni, D., Sansonetti, P. J., & Carlier, M.-F. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.6.1319 · Cited by 522
Suzuki-Inoue, K., Kato, Y., Inoue, O., Kaneko, M. K., Mishima, K., Yatomi, Y., Yamazaki, Y., Narimatsu, H., & Ozaki, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702327200 · Cited by 519
Vigon, I., Mornon, J. P., Cocault, L., Mitjavila, M. T., Tambourin, P., Gisselbrecht, S., & Souyri, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5640 · Cited by 509
Erythroblastic islands: niches for erythropoiesis
Chasis, J. A., & Mohandas, N. (2008) · Blood · doi:10.1182/blood-2008-03-077883 · Cited by 506
Polley, M. J., Phillips, M. L., Wayner, E., Nudelman, E., Singhal, A. K., Hakomori, S., & Paulson, J. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6224 · Cited by 492
Seminars in Thrombosis and Hemostasis
Schulman, S. (2026) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-00000077 · Cited by 486
Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
Chan, A. T. (2005) · JAMA · doi:10.1001/jama.294.8.914 · Cited by 478
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Cole, B. F., Logan, R. F., Halabi, S., Benamouzig, R., Sandler, R. S., Grainge, M. J., Chaussade, S., & Baron, J. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn485 · Cited by 476
Schmacke, N. (2024) · Vertrauen in die Medizin · doi:10.30820/9783837961249-13 · Cited by 465
Boucharaba, A., Serre, C.-M., Grès, S., Saulnier-Blache, J. S., Bordet, J.-C., Guglielmi, J., Clézardin, P., & Peyruchaud, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422123 · Cited by 462
P-selectin deficiency attenuates tumor growth and metastasis
Kim, Y. J., Borsig, L., Varki, N. M., & Varki, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9325 · Cited by 454
Platelet—tumor‐cell interactions in mice. The role of platelets in the spread of malignant disease
Gasic, G. J., Gasic, T. B., Galanti, N., Johnson, T., & Murphy, S. (1973) · International Journal of Cancer · doi:10.1002/ijc.2910110322 · Cited by 452
Bizzozero, J. (1882) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01931360 · Cited by 420
Epidemiology and pathophysiology of cancer-associated thrombosis
Noble, S., & Pasi, J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605599 · Cited by 396
Normal Structure, Function, and Histology of the Bone Marrow
Travlos, G. S. (2006) · Toxicologic Pathology · doi:10.1080/01926230600939856 · Cited by 370
THE AMERICAN JOURNAL OF PHYSIOLOGY
(1897) · Science · doi:10.1126/science.6.146.590 · Cited by 364
Klages, B., Brandt, U., Simon, M. I., Schultz, G., & Offermanns, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.4.745 · Cited by 363
Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches
Institute of Medical Sciences, F., Augello, A., Kurth, T., & De Bari, C. (2010) · European Cells and Materials · doi:10.22203/ecm.v020a11 · Cited by 358
Jurasz, P., Alonso‐Escolano, D., & Radomski, M. W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706013 · Cited by 357
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.
Mueller, B. M., Reisfeld, R. A., Edgington, T. S., & Ruf, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11832 · Cited by 356
The relationship between tissue factor and cancer progression: insights from bench and bedside
van den Berg, Y. W., Osanto, S., Reitsma, P. H., & Versteeg, H. H. (2012) · Blood · doi:10.1182/blood-2011-06-317685 · Cited by 354
Coller, B. S., & Shattil, S. J. (2008) · Blood · doi:10.1182/blood-2008-06-077891 · Cited by 352
Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo.
Karpatkin, S., Pearlstein, E., Ambrogio, C., & Coller, B. S. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113411 · Cited by 346
Suppression of Thromboxane A2but Not of Systemic Prostacyclin by Controlled-Release Aspirin
Clarke, R. J., Mayo, G., Price, P., & FitzGerald, G. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251605 · Cited by 346
North Carolina Medical Journal
(2023) · North Carolina Medical Journal · doi:10.18043/ncm · Cited by 346
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells
Erpenbeck, L., & Schön, M. P. (2010) · Blood · doi:10.1182/blood-2009-10-247296 · Cited by 345
Nieuwland, R., Berckmans, R. J., Rotteveel-Eijkman, R. C., Maquelin, K. N., Roozendaal, K. J., Jansen, P. G. M., Have, K. T., Eijsman, L., Hack, C. E., & Sturk, A. (1997) · Circulation · doi:10.1161/01.cir.96.10.3534 · Cited by 345
Gissen, P., Johnson, C. A., Morgan, N. V., Stapelbroek, J. M., Forshew, T., Cooper, W. N., McKiernan, P. J., Klomp, L. W. J., Morris, A. A. M., Wraith, J. E., et al. (2004) · Nature Genetics · doi:10.1038/ng1325 · Cited by 340
Growth factor content in PRP and their applicability in medicine.
Lubkowska, A., Dołęgowska, B., & Banfi, G. (2012) · PubMed · Cited by 339
Prostacyclin: A Potent Antimetastatic Agent
Honn, K. V., Cicone, B., & Skoff, A. (1981) · Science · doi:10.1126/science.7015512 · Cited by 331
Self-citationPlatelet microRNA-mRNA coexpression profiles correlate with platelet reactivity
Nagalla, S., Shaw, C., Kong, X., Kondkar, A. A., Edelstein, L. C., Ma, L., Chen, J., McKnight, G. S., López, J. A., Yang, L., et al. (2011) · Blood · doi:10.1182/blood-2010-09-299719 · Cited by 329
Harris, R. E. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-8049-8 · Cited by 329
Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors
Nutt, S. L., Metcalf, D., D'Amico, A., Polli, M., & Wu, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041535 · Cited by 325
Historical review: megakaryopoiesis and thrombopoiesis
Kaushansky, K. (2008) · Blood · doi:10.1182/blood-2007-05-088500 · Cited by 320
Kehrel, B., Wierwille, S., Clemetson, K. J., Anders, O., Steiner, M., Graham Knight, C., Farndale, R. W., Okuma, M., & Barnes, M. J. (1998) · Blood · doi:10.1182/blood.v91.2.491 · Cited by 317
Platelet-rich plasma (PRP) in dental and oral surgery: from the wound healing to bone regeneration
Albanese, A., Licata, M. E., Polizzi, B., & Campisi, G. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-23 · Cited by 316
Platelet Chemokines in Vascular Disease
Gleissner, C. A., von Hundelshausen, P., & Ley, K. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.169417 · Cited by 314
Novel roles of cAMP/cGMP‐dependent signaling in platelets
SMOLENSKI, A. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04576.x · Cited by 312
MicroRNA-Mediated Control of Cell Fate in Megakaryocyte-Erythrocyte Progenitors
Lu, J., Guo, S., Ebert, B. L., Zhang, H., Peng, X., Bosco, J., Pretz, J., Schlanger, R., Wang, J. Y., Mak, R. H., et al. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.03.012 · Cited by 310
MicroRNA miR-125a controls hematopoietic stem cell number
Guo, S., Lu, J., Schlanger, R., Zhang, H., Wang, J. Y., Fox, M. C., Purton, L. E., Fleming, H. H., Cobb, B., Merkenschlager, M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913574107 · Cited by 310
Arinobu, Y., Mizuno, S.-I., Chong, Y., Shigematsu, H., Iino, T., Iwasaki, H., Graf, T., Mayfield, R., Chan, S., Kastner, P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.004 · Cited by 309
Hinson, R. M., Williams, J. A., & Shacter, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4885 · Cited by 302
PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
Dakic, A., Metcalf, D., Di Rago, L., Mifsud, S., Wu, L., & Nutt, S. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050075 · Cited by 297
Thrombocytosis Associated With Malignant Disease
LEVIN, J. (1964) · Archives of Internal Medicine · doi:10.1001/archinte.1964.03860100079008 · Cited by 295
Platelets and cancer metastasis: A causal relationship?
Honn, K. V., Tang, D. G., & Crissman, J. D. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf01307186 · Cited by 289
Self-citationExome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome
Albers, C. A., Cvejic, A., Favier, R., Bouwmans, E. E., Alessi, M.-C., Bertone, P., Jordan, G., Kettleborough, R. N. W., Kiddle, G., Kostadima, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.885 · Cited by 285
Yago, T., Lou, J., Wu, T., Yang, J., Miner, J. J., Coburn, L., López, J. A., Cruz, M. A., Dong, J.-F., McIntire, L. V., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35754 · Cited by 280
Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome
Kahr, W. H., Hinckley, J., Li, L., Schwertz, H., Christensen, H., Rowley, J. W., Pluthero, F. G., Urban, D., Fabbro, S., Nixon, B., et al. (2011) · Nature Genetics · doi:10.1038/ng.884 · Cited by 277
Prostaglandins and cancer: A review of tumor initiation through tumor metastasis
Honn, K. V., Bockman, R. S., & Marnett, L. J. (1981) · Prostaglandins · doi:10.1016/0090-6980(81)90240-9 · Cited by 269
Self-citationNBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules
Gunay-Aygun, M., Falik-Zaccai, T. C., Vilboux, T., Zivony-Elboum, Y., Gumruk, F., Cetin, M., Khayat, M., Boerkoel, C. F., Kfir, N., Huang, Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.883 · Cited by 264
G13 is an essential mediator of platelet activation in hemostasis and thrombosis
Moers, A., Nieswandt, B., Massberg, S., Wettschureck, N., Grüner, S., Konrad, I., Schulte, V., Aktas, B., Gratacap, M.-P., Simon, M. I., et al. (2003) · Nature Medicine · doi:10.1038/nm943 · Cited by 264
Restructuring G-Protein- Coupled Receptor Activation
Audet, M., & Bouvier, M. (2012) · Cell · doi:10.1016/j.cell.2012.09.003 · Cited by 262
An electron microscope study of the megacaryocyte of the rat bone marrow
Behnke, O. (1968) · Journal of Ultrastructure Research · doi:10.1016/s0022-5320(68)80046-2 · Cited by 261
Schwer, H. D., Lecine, P., Tiwari, S., Italiano, J. E., Hartwig, J. H., & Shivdasani, R. A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00153-1 · Cited by 260
Selectin-carbohydrate interactions during inflammation and metastasis
McEver, R. P. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018584425879 · Cited by 253
Thrombin-induced protein phosphorylation in human platelets.
Lyons, R. M., Stanford, N., & Majerus, P. W. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108172 · Cited by 248
Large oncosomes mediate intercellular transfer of functional microRNA
Morello, M., Minciacchi, V., de Candia, P., Yang, J., Posadas, E., Kim, H., Griffiths, D., Bhowmick, N., Chung, L., Gandellini, P., et al. (2013) · Cell Cycle · doi:10.4161/cc.26539 · Cited by 244
Hartwig, J. H., & DeSisto, M. (1991) · The Journal of cell biology · doi:10.1083/jcb.112.3.407 · Cited by 234
(2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.1478_10.x · Cited by 233
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial
Baron, J. A., Sandler, R. S., Bresalier, R. S., Lanas, A., Morton, D. G., Riddell, R., Iverson, E. R., & DeMets, D. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61490-7 · Cited by 232
Platelets: Linking Hemostasis and Cancer
Jain, S., Harris, J., & Ware, J. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207514 · Cited by 232
Rac1 Is Essential for Platelet Lamellipodia Formation and Aggregate Stability under Flow
McCarty, O. J. T., Larson, M. K., Auger, J. M., Kalia, N., Atkinson, B. T., Pearce, A. C., Ruf, S., Henderson, R. B., Tybulewicz, V. L. J., Machesky, L. M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504672200 · Cited by 232
Molecular cloning and chromosomal localization of the human thrombopoietin gene
Sohma, Y., Akahori, H., Seki, N., Hori, T.-A., Ogami, K., Kato, T., Shimada, Y., Kawamura, K., & Miyazaki, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01008-0 · Cited by 227
Ezumi, Y., Shindoh, K., Tsuji, M., & Takayama, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.267 · Cited by 227
Munc13-4 Is a GTP-Rab27-binding Protein Regulating Dense Core Granule Secretion in Platelets
Shirakawa, R., Higashi, T., Tabuchi, A., Yoshioka, A., Nishioka, H., Fukuda, M., Kita, T., & Horiuchi, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309426200 · Cited by 221
MACHESKY, M. L., REEVES, E., WIENTJES, F., MATTHEYSE, J. F., GROGAN, A., TOTTY, F. N., BURLINGAME, L. A., HSUAN, J. J., & SEGAL, W. A. (1997) · Biochemical Journal · doi:10.1042/bj3280105 · Cited by 220
Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis
Takkouche, B., Regueira-Mendez, C., & Etminan, M. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn324 · Cited by 215
Niche-to-niche migration of bone-marrow-derived cells
Kaplan, R. N., Psaila, B., & Lyden, D. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.003 · Cited by 212
Mechanisms of organelle transport and capture along proplatelets during platelet production
Richardson, J. L., Shivdasani, R. A., Boers, C., Hartwig, J. H., & Italiano, J. E. (2005) · Blood · doi:10.1182/blood-2005-06-2206 · Cited by 210
Platelets in tissue repair: control of apoptosis and interactions with regenerative cells
Gawaz, M., & Vogel, S. (2013) · Blood · doi:10.1182/blood-2013-05-468694 · Cited by 210
Brandt, E., Petersen, F., Ludwig, A., Ehlert, J. E., Bock, L., & Flad, H.-D. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.4.471 · Cited by 208
The Origin and Nature of the Blood Plates
WRIGHT, J. H. (1906) · The Boston Medical and Surgical Journal · doi:10.1056/nejm190606071542301 · Cited by 206
Takagi, S., Sato, S., Oh-hara, T., Takami, M., Koike, S., Mishima, Y., Hatake, K., & Fujita, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073609 · Cited by 204
Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling
Eto, K., Murphy, R., Kerrigan, S. W., Bertoni, A., Stuhlmann, H., Nakano, T., Leavitt, A. D., & Shattil, S. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202380099 · Cited by 203
Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward
Menter, D. G., Schilsky, R. L., & DuBois, R. N. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0788 · Cited by 203
Self-citationThe role of platelet activation in tumor metastasis
Borsig, L. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.8.1247 · Cited by 199
Zimmet, J., & Ravid, K. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(99)00124-1 · Cited by 197
Platelet-Derived Microvesicles: Multitalented Participants in Intercellular Communication
Aatonen, M., Grönholm, M., & Siljander, P. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1300956 · Cited by 194
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Breazna, A., Kim, K., Tang, J., Rosenstein, R. B., Umar, A., Bagheri, D., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0206 · Cited by 193
Pearlstein, E., Salk, P. L., Yogeeswaran, G., & Karpatkin, S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4336 · Cited by 192
Perivascular support of human hematopoietic stem/progenitor cells
Corselli, M., Chin, C. J., Parekh, C., Sahaghian, A., Wang, W., Ge, S., Evseenko, D., Wang, X., Montelatici, E., Lazzari, L., et al. (2013) · Blood · doi:10.1182/blood-2012-08-451864 · Cited by 189
(1934) · British Journal of Urology · doi:10.1111/j.1464-410x.1934.tb11234.x · Cited by 185
Pleines, I., Hagedorn, I., Gupta, S., May, F., Chakarova, L., van Hengel, J., Offermanns, S., Krohne, G., Kleinschnitz, C., Brakebusch, C., et al. (2012) · Blood · doi:10.1182/blood-2011-08-372193 · Cited by 184
Lieberman, J. S. (1961) · JAMA · doi:10.1001/jama.1961.03040340006002 · Cited by 184
The platelet interior revisited: electron tomography reveals tubular α-granule subtypes
van Nispen tot Pannerden, H., de Haas, F., Geerts, W., Posthuma, G., van Dijk, S., & Heijnen, H. F. G. (2010) · Blood · doi:10.1182/blood-2010-02-268680 · Cited by 184
Rho GTPases in platelet function
ASLAN, J. E., & MCCARTY, O. J. T. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12051 · Cited by 183
Treatment of cancer-associated thrombosis
Lee, A. Y. Y., & Peterson, E. A. (2013) · Blood · doi:10.1182/blood-2013-04-460162 · Cited by 183
The demarcation membrane system of the megakaryocyte: a misnomer?
Radley, J., & Haller, C. (1982) · Blood · doi:10.1182/blood.v60.1.213.213 · Cited by 182
Abnet, C. C., Freedman, N. D., Kamangar, F., Leitzmann, M. F., Hollenbeck, A. R., & Schatzkin, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604880 · Cited by 181
Thrombopoietin and Thrombopoietin Mimetics in the Treatment of Thrombocytopenia
Kuter, D. J. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.181154 · Cited by 180
Carpinelli, M. R., Hilton, D. J., Metcalf, D., Antonchuk, J. L., Hyland, C. D., Mifsud, S. L., Di Rago, L., Hilton, A. A., Willson, T. A., Roberts, A. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401496101 · Cited by 179
Hierarchical Differentiation of Myeloid Progenitors Is Encoded in the Transcription Factor Network
Krumsiek, J., Marr, C., Schroeder, T., & Theis, F. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022649 · Cited by 179
P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer.
Stone, J. P., & Wagner, D. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116654 · Cited by 179
Zucker, M. B., & Nachmias, V. T. (1985) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.5.1.2 · Cited by 179
ALEMAN, M. M., GARDINER, C., HARRISON, P., & WOLBERG, A. S. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04488.x · Cited by 178
Journal of the National Cancer Institute
National Cancer Institute (2020) · Definitions · doi:10.32388/qmb9l1 · Cited by 178
THE FINE STRUCTURE OF THE MEGAKARYOCYTE IN THE MOUSE SPLEEN
Yamada, E. (1957) · Cells Tissues Organs · doi:10.1159/000141169 · Cited by 177
Mahoney, N. M., Janmey, P. A., & Almo, S. C. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb1197-953 · Cited by 171
A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis
Zhang, L., Orban, M., Lorenz, M., Barocke, V., Braun, D., Urtz, N., Schulz, C., von Brühl, M.-L., Tirniceriu, A., Gaertner, F., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20121090 · Cited by 171
Lordier, L., Bluteau, D., Jalil, A., Legrand, C., Pan, J., Rameau, P., Jouni, D., Bluteau, O., Mercher, T., Leon, C., et al. (2012) · Nature Communications · doi:10.1038/ncomms1704 · Cited by 170
Schmitt, A., Guichard, J., Massé, J., Debili, N., & Cramer, E. M. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00733-0 · Cited by 169
BERNARDO, A., BALL, C., NOLASCO, L., CHOI, H., MOAKE, J. L., & DONG, J. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01122.x · Cited by 168
Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells
Nagasawa, T., Omatsu, Y., & Sugiyama, T. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.03.009 · Cited by 167
The organizing principle of the platelet glycoprotein Ib–IX–V complex
Li, R., & Emsley, J. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12144 · Cited by 167
Stalker, T. J., Newman, D. K., Ma, P., Wannemacher, K. M., & Brass, L. F. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-29423-5_3 · Cited by 167
Qureshi, A. H., Chaoji, V., Maiguel, D. A., Faridi, M. H., Barth, C. J., Salem, S. M., Singhal, M., Stoub, D. G., Krastins, B., Ogihara, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007627 · Cited by 165
Do all roads lead to Rome? Routes to metastasis development
Sleeman, J. P., Nazarenko, I. A., & Thiele, W. (2011) · International Journal of Cancer · doi:10.1002/ijc.26027 · Cited by 162
E-type prostanoid receptor 4 (EP4) in disease and therapy
Konya, V., Marsche, G., Schuligoi, R., & Heinemann, A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.006 · Cited by 158
Williams, S. C. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304186110 · Cited by 158
Crissman, J. D., Hatfield, J. S., Menter, D. G., Sloane, B. F., & Honn, K. V. (1988) · PubMed · Cited by 156
Self-citationSignalling through the platelet glycoprotein Ib-V–IX complex
Canobbio, I., Balduini, C., & Torti, M. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.05.008 · Cited by 155
Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival
Pai, V. P., Marshall, A. M., Hernandez, L. L., Buckley, A. R., & Horseman, N. D. (2009) · Breast Cancer Research · doi:10.1186/bcr2448 · Cited by 155
Chen, D., Bernstein, A. M., Lemons, P. P., & Whiteheart, S. W. (2000) · Blood · doi:10.1182/blood.v95.3.921.003k17_921_929 · Cited by 153
Patel-Hett, S. R., Richardson, J. L., Schulze, H., Drabek, K., Isaac, N. A., Hoffmeister, K. M., Shivdasani, R. A., Bulinski, J. C., Galjart, N., Hartwig, J. H., et al. (2008) · Blood · doi:10.1182/blood-2007-10-118844 · Cited by 153
Kamykowski, J. A., Carlton, P. M., Sehgal, S., & Storrie, B. (2011) · Blood · doi:10.1182/blood-2011-01-330910 · Cited by 152
Young, A., Chapman, O., Connor, C., Poole, C., Rose, P., & Kakkar, A. K. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.106 · Cited by 150
Coordinated regulation of platelet actin filament barbed ends by gelsolin and capping protein.
Barkalow, K. L., Witke, W., Kwiatkowski, D. J., & Hartwig, J. H. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.134.2.389 · Cited by 144
Regulation of proplatelet formation and platelet release by integrin αIIbβ3
Larson, M. K., & Watson, S. P. (2006) · Blood · doi:10.1182/blood-2005-11-011957 · Cited by 143
THE CARCINOGENIC EFFECT OF A PAPILLOMA VIRUS ON THE TARRED SKIN OF RABBITS
Rous, P., & Kidd, J. G. (1938) · The Journal of Experimental Medicine · doi:10.1084/jem.67.3.399 · Cited by 142
Crissman, J. D., Hatfield, J. S., Schaldenbrand, M. F., Sloane, B. F., & Honn, K. V. (1985) · PubMed · Cited by 142
Self-citationActivated Platelets and Monocytes Generate Four Hydroxyphosphatidylethanolamines via Lipoxygenase
Maskrey, B. H., Bermúdez-Fajardo, A., Morgan, A. H., Stewart-Jones, E., Dioszeghy, V., Taylor, G. W., Baker, P. R. S., Coles, B., Coffey, M. J., Kühn, H., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611776200 · Cited by 142
The vascular niche: home for normal and malignant hematopoietic stem cells
Doan, P. L., & Chute, J. P. (2011) · Leukemia · doi:10.1038/leu.2011.236 · Cited by 140
Chapter 1 Ontogeny of Erythropoiesis in the Mammalian Embryo
McGrath, K. E., & Palis, J. (2008) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)00001-4 · Cited by 139
Tissue Factor and PAR2 Signaling in the Tumor Microenvironment
Schaffner, F., & Ruf, W. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.177428 · Cited by 139
Kurrasch‐Orbaugh, D. M., Parrish, J. C., Watts, V. J., & Nichols, D. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01921.x · Cited by 138
Regulation of megakaryocyte maturation and platelet formation
Bluteau, D., Lordier, L., Stefano, A. D., Chang, Y., Raslová, H., Debili, N., & Vainchenker, W. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03398.x · Cited by 138
Transmigration of Lymph Nodes by Tumor Cells
Fisher, B., & Fisher, E. R. (1966) · Science · doi:10.1126/science.152.3727.1397 · Cited by 137
Transporters in human platelets: physiologic function and impact for pharmacotherapy
Jedlitschky, G., Greinacher, A., & Kroemer, H. K. (2012) · Blood · doi:10.1182/blood-2011-09-336933 · Cited by 136
Cyclic 3′,5′-Adenosine Monophosphate in Human Blood Platelets
Salzman, E. W., & Neri, L. L. (1969) · Nature · doi:10.1038/224609a0 · Cited by 136
Platelet CLEC-2 and podoplanin in cancer metastasis
Lowe, K. L., Navarro‐Núñez, L., & Watson, S. P. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70013-0 · Cited by 135
Rolfe, B. E., Worth, N. F., WORLD, C., Campbell, J. H., & CAMPBELL, G. R. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.023 · Cited by 134
Thon, J. N., & Italiano, J. E. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.03.005 · Cited by 134
Novel platelet activation receptor CLEC‐2: from discovery to prospects
Suzuki-Inoue, K., Inoue, O., & Ozaki, Y. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04335.x · Cited by 133
Jones, D. S., Wallace, A. C., & Fraser, E. E. (1971) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/46.3.493 · Cited by 133
Research works printed but not linked: 152
- Rados, C. (2004). Beyond bloodletting: FDA gives leeches a medical makeover. FDA Consumer, 38(5), 9.
- Winkel, R., Tajsic, N., Husum, H., Schlageter, M., Hanebuth, G., & Hoffmann, R. (2013). Saphenous perforator flap. Operative Orthopädie und Traumatologie, 25(2), 152–161. · doi:10.1007/s00064-012-0198-z
- Steinhubl, S. R. (2011). Historical observations on the discovery of platelets, platelet function testing and the first antiplatelet agent. Current Drug Targets, 12(12), 1792–1804. · doi:10.2174/138945011797635858
- Addison, W. (1842). On the colourless corpuscles and on the molecules and cytoblasts in the blood. London Med Gaz, 30, 144–152.
- Schultze, M. (1865). Ein heizbarer Objecttisch und seine Verwendung bei Untersuchungen des Blutes. Arch Mikrosc Anatomy, 1, 1–42. · doi:10.1007/bf02961404
- de Gaetano, G. (2001). A new blood corpuscle: an impossible interview with Giulio Bizzozero. Thrombosis and Haemostasis, 86(4), 973–979.
- Bizzozero, G. (1869). Sul midollo delle ossa. Napoli: Tipografia Italiana.
- Osler, W., & Schäfer, E. A. (1873). über einige im Blute vorhandene bacterienbildende Massen. Centralbl Medicine Wissensch, 11, 577–578.
- Howell, W. H. (1890). Observations upon the occurrence, structure, and function of the giant cells of the marrow. Journal of Morphology, 4, 117–130. · doi:10.1002/jmor.1050040106
- Wright, J. H. (1910). The histogenesis of blood platelets. Journal of Morphology, 21, 263–278. · doi:10.1002/jmor.1050210204
- Nakeff, A., & Maat, B. (1974). Separation of megakaryocytes from mouse bone marrow by velocity sedimentation. Blood, 43(4), 591–595. · doi:10.1182/blood.v43.4.591.591
- Pease, D. C. (1956). An electron microscopic study of red bone marrow. Blood, 11(6), 501–526. · doi:10.1182/blood.v11.6.501.501
- Bariety, M. (1947). Trousseau, 1801–1867 (pp. 234–235). Geneva: Mazenod.
- Osler, W., & McCrae, T. (1900). Latent cancer of the stomach. Phil Medical Journal, 5, 245.
- Henderson, P. H., Jr. (1955). Multiple migratory thrombophlebitis associated with ovarian carcinoma. American Journal of Obstetrics and Gynecology, 70(2), 452–453. · doi:10.1016/s0002-9378(16)37699-2
- Jarniou, A. P., & Moreau, A. (1959). Recurrent & migratory thrombophlebitis revealing a secondary cancer with mediastino-pulmonary form. Presse Médicale, 67(27), 1117–1118.
- Jennings, W., & Russel, W. (1948). Phlebothrombosis associated with mucin-producing carcinomas of the tail and body of the pancreas. Archives of Surgery, 56, 186–198. · doi:10.1001/archsurg.1948.01240010191009
- Kenney, W. (1943). The association of carcinoma in the body and tail of the pancreas with multiple venous thrombi. Surgery, 14, 600–609.
- Linquette, M., Mesmacque, R., Fossati, P., Luez, G., & Beghin, B. (1964). Recurrent and migratory venous thromboses. Prog ress in Medical (Paris), 92, 689–698.
- Mainoli, S., & Piccinelli, O. (1956). Migratory thrombophlebitis and malignant tumors; migratory thrombophlebitis occurring during two cases of reticulosarcoma. La Riforma Medica, 70(46), 1330–1334.
- Picard, R., Horeau, J., Guillon, J., & Robin, C. (1959). Migratory thrombophlebitis & bronchopulmonary cancer. Bulletins et Mémoires de la Société Médicale des Hôpitaux de Paris, 75(9–11), 327–329.
- Popesco, I., & Ciobanu, V. (1958). Migratory thrombophlebitis as a manifestation of visceral cancer. La Semaine des Hôpitaux, 34(1), 26–30.
- Rizzo, J. A. (1956). Migratory thrombophlebitis and visceral cancer. Revista de la Asociación Médica Argentina, 70(825–826), 236–238.
- Womack, W. S., & Castellano, C. J. (1952). Migratory thrombophlebitis associated with ovarian carcinoma. American Journal of Obstetrics and Gynecology, 63(2), 467–469. · doi:10.1016/s0002-9378(15)32851-9
- Brugarolas, A., Elias, E. G., Takita, H., Mink, I. B., Mittelman, A., & Ambrus, J. L. (1973). Blood coagulation and fibrinolysis in patients with carcinoma of the lung. Journal of Medicine, 4(2), 96–105.
- Peterson, H. I., Appelgren, K. L., & Rosengren, B. H. (1969). Fibrinogen metabolism in experimental tumours. European Journal of Cancer, 5(6), 535–542. · doi:10.1016/0014-2964(69)90001-2
- Peterson, H. I., Appelgren, K. L., & Rosengren, B. H. (1972). Experimental studies on the mechanisms of fibrinogen uptake in a rat tumour. European Journal of Cancer, 8(6), 677–681. · doi:10.1016/0014-2964(72)90151-x
- Gastpar, H. (1973). Inhibition of “cancer cell stickiness” through bencylan-hydrogen fumarate (fluditate). Fortschritte der Medizin, 91(33), 1322–1328.
- Hilgard, P. (1973). The role of blood platelets in experimental metastases. British Journal of Cancer, 28(5), 429–435. · doi:10.1038/bjc.1973.168
- Warren, B. A. (1973). Environment of the blood-borne tumor embolus adherent to vessel wall. Journal of Medicine, 4(3), 150–177.
- Warren, B. A., & Vales, O. (1972). The adhesion of thromboplastic tumour emboli to vessel walls in vivo. British Journal of Experimental Pathology, 53(3), 301–313.
- Cliffton, E. E., & Grossi, C. E. (1956). Effect of human plasmin on the toxic effects and growth of blood borne metastatis of the Brown-Pearce carcinoma and the V2 carcinoma of rabbit. Cancer, 9(6), 1147–1152. · doi:10.1002/1097-0142(195611/12)9:6<1147::aid-cncr2820090613>3.0.co;2-u
- Johnson, J. H., & Woods, J. R. (1963). An in vitro study of fibrinolytic agents on V2 carcinoma cells and intravascular thrombi in rabbits. Bulletin of the Johns Hopkins Hospital, 113, 335–346.
- Pearce, L., & Brown, W. H. (1923). Studies based on a malignant tumor of the rabbit: V. Metastases. Part 1. Description of the lesions with especial reference to their occurrence and distribution. The Journal of Experimental Medicine, 38(4), 347–366. · doi:10.1084/jem.38.4.347
- Woods, J. R. (1964). Experimental studies of the intravascular dissemination of ascitic V2 carcinoma cells in the rabbit, with special reference to fibrinogen and fibrinolytic agents. Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, 20, 92–121.
- Fidler, I. J. (1970). Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine. Journal of the National Cancer Institute, 45(4), 773–782.
- Honn, K. V., Menter, D., Cavanaugh, P. G., Neagos, G., Moilanen, D., Taylor, J. D., et al. (1983). A review of prostaglandins and the treatment of tumor metastasis. Acta Clinica Belgica, 38(1), 53–67. · doi:10.1080/22953337.1983.11718906
- Menter, D. G., Harkins, C., Onoda, J., Riorden, W., Sloane, B. F., Taylor, J. D., et al. (1987). Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study. Invasion & Metastasis, 7(2), 109–128.
- Cavanaugh, P. G., Sloane, B. F., Bajkowski, A. S., Gasic, G. J., Gasic, T. B., & Honn, K. V. (1983). Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clinical & Experimental Metastasis, 1(4), 297–307. · doi:10.1007/bf00121192
- Menter, D. G., Hatfield, J. S., Harkins, C., Sloane, B. F., Taylor, J. D., Crissman, J. D., et al. (1987). Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells. Clinical & Experimental Metastasis, 5(1), 65–78. · doi:10.1007/bf00116627
- Sloane, B. F., Rozhin, J., Hatfield, J. S., Crissman, J. D., & Honn, K. V. (1987). Plasma membrane-associated cysteine proteinases in human and animal tumors. Experimental Cell Biology, 55(4), 209–224.
- White, J. G. (1967). A simple method for preservation of fine structure in blood cells. Thrombosis et Diathesis Haemorrhagica, 18(3–4), 745–753.
- White, J. G., & Krivit, W. (1967). The canalicular system of blood platelets: apossible sarcoplasmic reticulum. The Journal of Laboratory and Clinical Medicine, 49, 60.
- White, J. G., & Krivit, W. (1967). Changes in platelet microtubules and granules during early clot development. Thrombosis et Diathesis Haemorrhagica. Supplementum, 26, 29–42.
- Grossi, I. M., Fitzgerald, L. A., Kendall, A., Taylor, J. D., Sloane, B. F., & Honn, K. V. (1987). Inhibition of human tumor cell induced platelet aggregation by antibodies to platelet glycoproteins Ib and IIb/IIIa. Proceedings of the Society for Experimental Biology and Medicine, 186(3), 378–383. · doi:10.3181/00379727-186-3-rc1
- Vitrat, N., Letestu, R., Masse, A., Lazar, V., Vainchenker, W., & Debili, N. (2000). Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiation. Thrombosis and Haemostasis, 83(5), 759–768. · doi:10.1055/s-0037-1613905
- Hussein, K., Dralle, W., Theophile, K., Kreipe, H., & Bock, O. (2009). Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm. Annals of Hematology, 88(4), 325–332. · DOI
- Lin, J., & Zhan, R. (2011). Advance of studies on role of miRNA in hematopoietic regulation and myeloproliferative neoplasms. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 19(4), 1071–1074.
- Kaushansky, K. (1994). The mpl ligand: molecular and cellular biology of the critical regulator of megakaryocyte development. Stem Cells, 12(Suppl 1), 91–96. discussion 96-97.
- Neumann, T. A., & Foote, M. (2000). Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis. Cytokines, Cellular & Molecular Therapy, 6(1), 47–56. · doi:10.1080/13684730050515912
- Dong-Feng, Z., Ting, L., Yong, Z., Cheng, C., Xi, Z., & Pei-Yan, K. (2013). The TPO/c-MPL pathway in the bone marrow may protect leukemia cells from chemotherapy in AML patients. Pathology and Oncology Research. doi: 10.1007/s12253-013-9696-z . · doi:10.1007/s12253-013-9696-z
- Cosgrove, L. J., Sandrin, M. S., Rajasekariah, P., & McKenzie, I. F. (1986). A genomic clone encoding the alpha chain of the OKM1, LFA-1, and platelet glycoprotein IIb-IIIa molecules. Proceedings of the National Academy of Sciences of the United States of America, 83(3), 752–756. · doi:10.1073/pnas.83.3.752
- Fitzgerald, L. A., Poncz, M., Steiner, B., Rall, S. C., Jr., Bennett, J. S., & Phillips, D. R. (1987). Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIb. Biochemistry, 26(25), 8158–8165. · doi:10.1021/bi00399a021
- Lanza, F., Kieffer, N., Phillips, D. R., & Fitzgerald, L. A. (1990). Characterization of the human platelet glycoprotein IIIa gene. Comparison with the fibronectin receptor beta-subunit gene. The Journal of Biological Chemistry, 265(30), 18098–18103. · doi:10.1016/s0021-9258(17)44722-3
- Miyazaki, H. (1996). Physiologic role of TPO in thrombopoiesis. Stem Cells, 14(Suppl 1), 133–138. · doi:10.1002/stem.5530140717
- Monzen, S., Takahashi, K., Yoshino, H., Kasai-Eguchi, K., & Kashiwakura, I. (2011). Terminal maturation of megakaryocytes and platelet production by hematopoietic stem cells irradiated with heavy-ion beams. Radiation Research, 176(1), 8–16. · doi:10.1667/rr2392.1
- Wang, W., Gilligan, D. M., Sun, S., Wu, X., & Reems, J. A. (2011). Distinct functional effects for dynamin 3 during megakaryocytopoiesis. Stem Cells and Development, 20(12), 2139–2151. · doi:10.1089/scd.2011.0159
- Patel-Hett, S., Wang, H., Begonja, A. J., Thon, J. N., Alden, E. C., Wandersee, N. J., et al. (2011). The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation. Blood, 118(6), 1641–1652. · doi:10.1182/blood-2011-01-330688
- Dhanjal, T. S., Pendaries, C., Ross, E. A., Larson, M. K., Protty, M. B., Buckley, C. D., et al. (2007). A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice. Blood, 109(10), 4237–4244. · doi:10.1182/blood-2006-10-050740
- Reddi, A. H., Gay, R., Gay, S., & Miller, E. J. (1977). Transitions in collagen types during matrix-induced cartilage, bone, and bone marrow formation. Proceedings of the National Academy of Sciences of the United States of America, 74(12), 5589–5592. · doi:10.1073/pnas.74.12.5589
- Zou, Z., Schmaier, A. A., Cheng, L., Mericko, P., Dickeson, S. K., Stricker, T. P., et al. (2009). Negative regulation of activated alpha-2 integrins during thrombopoiesis. Blood, 113(25), 6428–6439. · doi:10.1182/blood-2008-08-175356
- Schachtner, H., Calaminus, S. D., Sinclair, A., Monypenny, J., Blundell, M. P., Leon, C., et al. (2013). Megakaryocytes assemble podosomes that degrade matrix and protrude through basement membrane. Blood, 121(13), 2542–2552. · doi:10.1182/blood-2012-07-443457
- Kunert, S., Meyer, I., Fleischhauer, S., Wannack, M., Fiedler, J., Shivdasani, R. A., et al. (2009). The microtubule modulator RanBP10 plays a critical role in regulation of platelet discoid shape and degranulation. Blood, 114(27), 5532–5540. · doi:10.1182/blood-2009-04-216804
- Mazhuga, P. M., & Nosova, L. I. (1975). Proliferative characteristics of the endothelial cells and pericytes from the capillary vessels of rabbit bone marrow. Tsitologiia i Genetika, 9(5), 416–419.
- Lu, X. G., Zhu, L., Wang, W. Q., Zhang, X. H., Zhao, X. Y., Xu, G. B., et al. (2005). Morphological study on the megakaryocytes with nuclear extrusion and nucleocytoplasmic separation in four cases. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 13(6), 1082–1085.
- Hartwig, J. H., & Italiano, J. E., Jr. (2006). Cytoskeletal mechanisms for platelet production. Blood Cells, Molecules & Diseases, 36(2), 99–103. · doi:10.1016/j.bcmd.2005.12.007
- Italiano, J. E., Jr., Bergmeier, W., Tiwari, S., Falet, H., Hartwig, J. H., Hoffmeister, K. M., et al. (2003). Mechanisms and implications of platelet discoid shape. Blood, 101(12), 4789–4796. · doi:10.1182/blood-2002-11-3491
- Premsler, T., Lewandrowski, U., Sickmann, A., & Zahedi, R. P. (2011). Phosphoproteome analysis of the platelet plasma membrane. Methods in Molecular Biology, 728, 279–290. · doi:10.1007/978-1-61779-068-3_19
- Senis, Y., & Garcia, A. (2012). Platelet proteomics: state of the art and future perspective. Methods in Molecular Biology, 788, 367–399. · DOI
- Parguina, A. F., Rosa, I., & Garcia, A. (2012). Proteomics applied to the study of platelet-related diseases: aiding the discovery of novel platelet biomarkers and drug targets. Journal of Proteomics, 76, 275–286. · doi:10.1016/j.jprot.2012.04.043
- Schulz, C., Leuschen, N. V., Frohlich, T., Lorenz, M., Pfeiler, S., Gleissner, C. A., et al. (2010). Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood, 115(20), 4102–4110. · doi:10.1182/blood-2009-07-230268
- Wright, B., Stanley, R. G., Kaiser, W. J., Mills, D. J., & Gibbins, J. M. (2011). Analysis of protein networks in resting and collagen receptor (GPVI)-stimulated platelet sub-proteomes. Proteomics, 11(23), 4588–4592. · DOI
- Steinert, B. W., Tang, D. G., Grossi, I. M., Umbarger, L. A., & Honn, K. V. (1993). Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation. International Journal of Cancer, 54(1), 92–101. · doi:10.1002/ijc.2910540116
- Radley, J. M., & Hartshorn, M. A. (1987). Megakaryocyte fragments and the microtubule coil. Blood Cells, 12(3), 603–614.
- Escolar, G., Leistikow, E., & White, J. G. (1989). The fate of the open canalicular system in surface and suspension-activated platelets. Blood, 74(6), 1983–1988. · doi:10.1182/blood.v74.6.1983.1983
- Cranmer, S. L., Pikovski, I., Mangin, P., Thompson, P. E., Domagala, T., Frazzetto, M., et al. (2005). Identification of a unique filamin A binding region within the cytoplasmic domain of glycoprotein Ibalpha. The Biochemical Journal, 387(Pt 3), 849–858. · doi:10.1042/bj20041836
- Mangin, P., David, T., Lavaud, V., Cranmer, S. L., Pikovski, I., Jackson, S. P., et al. (2004). Identification of a novel 14-3-3zeta binding site within the cytoplasmic tail of platelet glycoprotein Ibalpha. Blood, 104(2), 420–427. · doi:10.1182/blood-2003-08-2881
- Mu, F. T., Andrews, R. K., Arthur, J. F., Munday, A. D., Cranmer, S. L., Jackson, S. P., et al. (2008). A functional 14-3-3zeta-independent association of PI3-kinase with glycoprotein Ib alpha, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex. Blood, 111(9), 4580–4587. · doi:10.1182/blood-2007-09-111096
- De Caterina, R., Marchetti, P., Bernini, W., Giannarelli, R., Giannessi, D., & Navalesi, R. (1989). The direct effects of metformin on platelet function in vitro. European Journal of Clinical Pharmacology, 37(2), 211–213. · doi:10.1007/bf00558236
- Wiwanitkit, V. (2011). Metformin high dosage and bleeding episode: a clinical case study. Indian Journal of Endocrinology and Metabolism, 15(2), 132–133. · doi:10.4103/2230-8210.81947
- Harper, M. T., & Poole, A. W. (2013). Chloride channels are necessary for full platelet phosphatidylserine exposure and procoagulant activity. Cell Death and Disease, 4, e969. · doi:10.1038/cddis.2013.495
- Tamaru, S., Fukuta, T., Kaibuchi, K., Matsuoka, Y., Shiku, H., & Nishikawa, M. (2005). Rho-kinase induces association of adducin with the cytoskeleton in platelet activation. Biochemical and Biophysical Research Communications, 332(2), 347–351. · doi:10.1016/j.bbrc.2005.04.127
- Lind, S. E., Yin, H. L., & Stossel, T. P. (1982). Human platelets contain gelsolin. A regulator of actin filament length. Journal of Clinical Investigation, 69(6), 1384–1387. · doi:10.1172/jci110578
- Wang, L. L., & Bryan, J. (1981). Isolation of calcium-dependent platelet proteins that interact with actin. Cell, 25(3), 637–649. · doi:10.1016/0092-8674(81)90171-9
- Davidson, M. M., & Haslam, R. J. (1994). Dephosphorylation of cofilin in stimulated platelets: roles for a GTP-binding protein and Ca2+. The Biochemical Journal, 301(Pt 1), 41–47. · doi:10.1042/bj3010041
- White, J. G. (1972). Exocytosis of secretory organelles from blood platelets incubated with cationic polypeptides. The American Journal of Pathology, 69(1), 41–54.
- White, J. G., & Estensen, R. D. (1972). Degranulation of discoid platelets. The American Journal of Pathology, 68(2), 289–302.
- Marks, M. S. (2012). SNARing platelet granule secretion. Blood, 120(12), 2355–2357. · doi:10.1182/blood-2012-07-442756
- Fukami, M. H., & Salganicoff, L. (1977). Human platelet storage organelles. A review. Thrombosis and Haemostasis, 38(4), 963–970. · doi:10.1055/s-0038-1651914
- Emiliani, C., Martino, S., Orlacchio, A., Vezza, R., Nenci, G. G., & Gresele, P. (1995). Platelet glycohydrolase activities: characterization and release. Cell Biochemistry and Function, 13(1), 31–39. · doi:10.1002/cbf.290130108
- Gordon, J. L. (1975). Blood platelet lysosomes and their contribution to the pathophysiological role of platelets. Frontiers of Biology, 43(4), 3–31.
- Metzelaar, M. J., & Clevers, H. C. (1992). Lysosomal membrane glycoproteins in platelets. Thrombosis and Haemostasis, 68(4), 378–382. · doi:10.1055/s-0038-1646280
- Waite, M., & Griffin, H. D. (1976). The phospholipases A of lysosomes. Frontiers of Biology, 45, 257–305.
- Sabetkar, M., Naseem, K. M., Tullett, J. M., Friebe, A., Koesling, D., & Bruckdorfer, K. R. (2001). Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein. Nitric Oxide, 5(3), 233–242. · doi:10.1006/niox.2001.0343
- Dutta-Roy, A. K., & Sinha, A. K. (1987). Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. The Journal of Biological Chemistry, 262(26), 12685–12691. · doi:10.1016/s0021-9258(18)45261-1
- Dittrich, M., Birschmann, I., Mietner, S., Sickmann, A., Walter, U., & Dandekar, T. (2008). Platelet protein interactions: map, signaling components, and phosphorylation groundstate. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(7), 1326–1331. · doi:10.1161/atvbaha.107.161000
- Yamanaka, M., Kume, S., Kariya, T., & Tanabe, A. (1979). cAMP-dependent protein kinase in human platelets and effect of prostaglandin E1 on its endogenous substrates (author’s transl). Nihon Ketsueki Gakkai Zasshi, 42(3), 541–542.
- Sand, C., Grandoch, M., Borgermann, C., Oude Weernink, P. A., Mahlke, Y., Schwindenhammer, B., et al. (2010). 8-pCPT-conjugated cyclic AMP analogs exert thromboxane receptor antagonistic properties. Thrombosis and Haemostasis, 103(3), 662–678. · doi:10.1160/th09-06-0341
- Siess, W., Winegar, D. A., & Lapetina, E. G. (1990). Rap1-B is phosphorylated by protein kinase A in intact human platelets. Biochemical and Biophysical Research Communications, 170(2), 944–950. · doi:10.1016/0006-291x(90)92182-y
- Marquis, N. R., Vigdahl, R. L., & Tavormina, P. A. (1969). Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1. Biochemical and Biophysical Research Communications, 36(6), 965–972. · doi:10.1016/0006-291x(69)90298-8
- Salzman, E. W. (1967). ADP-platelet aggregation. Thrombosis et Diathesis Haemorrhagica. Supplementum, 26, 197–199.
- Brodie, G. N., Baenziger, N. L., Chase, L. R., & Majerus, P. W. (1972). The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets. The Journal of Clinical Investigation, 51(1), 81–88. · doi:10.1172/jci106800
- Watanabe, N. (2010). RIAM: bridge between Rap1 and integrin. Rinshō Ketsueki, 51(6), 377–383.
- Huang, J. S., Dong, L., Kozasa, T., & Le Breton, G. C. (2007). Signaling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion. The Journal of Biological Chemistry, 282(14), 10210–10222. · doi:10.1074/jbc.m605678200
- Itoh, K., Hara, T., & Shibata, N. (1992). Diphosphorylation of platelet myosin by myosin light chain kinase. Biochimica et Biophysica Acta, 1133(3), 286–292. · doi:10.1016/0167-4889(92)90049-h
- Coburn, L. A., Damaraju, V. S., Dozic, S., Eskin, S. G., Cruz, M. A., & McIntire, L. V. (2011). GPIbalpha-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease. Biophysical Journal, 100(2), 304–312. · doi:10.1016/j.bpj.2010.11.084
- Colace, T. V., & Diamond, S. L. (2013). Direct observation of von Willebrand factor elongation and fiber formation on collagen during acute whole blood exposure to pathological flow. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(1), 105–113. · doi:10.1161/atvbaha.112.300522
- Clemetson, K. J. (2007). A short history of platelet glycoprotein Ib complex. Thrombosis and Haemostasis, 98(1), 63–68.
- Bernard, J., & Soulier, J. (1948). Sur une nouvelle variété de dystrophie thrombocytaire-hémorragipare congénitale. Semin Hôp Paris, 24, 3217–3223.
- Gardiner, E. E., Arthur, J. F., Berndt, M. C., & Andrews, R. K. (2005). Role of calmodulin in platelet receptor function. Current Medicinal Chemistry. Cardiovascular and Hematological Agents, 3(4), 283–287. · doi:10.2174/156801605774322283
- De Ceunynck, K., De Meyer, S. F., & Vanhoorelbeke, K. (2013). Unwinding the von Willebrand factor strings puzzle. Blood, 121(2), 270–277. · doi:10.1182/blood-2012-07-442285
- Nurden, A. T., & Caen, J. P. (1974). An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. British Journal of Haematology, 28(2), 253–260. · doi:10.1111/j.1365-2141.1974.tb06660.x
- Phillips, D. R., Jenkins, C. S., Luscher, E. F., & Larrieu, M. (1975). Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature, 257(5527), 599–600. · doi:10.1038/257599a0
- Glanzmann, E. (1918). Hereditare hammorhagische thrombastehnie. Beitr Pathologie Bluplatchen J Kinderkt, 88, 113–141.
- Clemetson, K. J. (1995). Platelet activation: signal transduction via membrane receptors. Thrombosis and Haemostasis, 74(1), 111–116. · doi:10.1055/s-0038-1642662
- Asselin, J., Knight, C. G., Farndale, R. W., Barnes, M. J., & Watson, S. P. (1999). Monomeric (glycine-proline-hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI. The Biochemical Journal, 339(Pt 2), 413–418. · doi:10.1042/0264-6021:3390413
- Zahid, M., Mangin, P., Loyau, S., Hechler, B., Billiald, P., Gachet, C., et al. (2012). The future of glycoprotein VI as an antithrombotic target. Journal of Thrombosis and Haemostasis, 10(12), 2418–2427. · doi:10.1111/jth.12009
- Ordonez, N. G. (2013). Value of podoplanin as an immunohistochemical marker in tumor diagnosis: a review and update. Applied Immunohistochemistry & Molecular Morphology.
- Watson, A. A., & O'Callaghan, C. A. (2005). Crystallization and X-ray diffraction analysis of human CLEC-2. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications, 61(Pt 12), 1094–1096. · doi:10.1107/s1744309105037991
- Suzuki-Inoue, K., Inoue, O., & Ozaki, Y. (2011). The novel platelet activation receptor CLEC-2. Platelets, 22(5), 380–384. · doi:10.3109/09537104.2011.556274
- Zimmermann, H. (1999). Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis. Nature Medicine, 5(9), 987–988. · doi:10.1038/12419
- Nathan, P. (1973). The migration of human platelets in vitro. Thrombosis et Diathesis Haemorrhagica, 30(1), 173–177.
- Brown, P. (2005). Lymphatic system: unlocking the drains. Nature, 436(7050), 456–458. · doi:10.1038/436456a
- Bouvenot, G., Escande, M., Xeridat, B., Simonin, G., Boucoiran, J., & Delboy, C. (1977). Thrombocytosis and cancer. Apropos of a chronological series of 100 patients. La Semaine des Hôpitaux, 53(36), 1921–1925.
- Rank, A., Liebhardt, S., Zwirner, J., Burges, A., Nieuwland, R., & Toth, B. (2012). Circulating microparticles in patients with benign and malignant ovarian tumors. Anticancer Research, 32(5), 2009–2014.
- van Doormaal, F., Kleinjan, A., Berckmans, R. J., Mackman, N., Manly, D., Kamphuisen, P. W., et al. (2012). Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thrombosis and Haemostasis, 108(1), 160–165. · doi:10.1160/th12-02-0099
- Rank, A., Nieuwland, R., Roesner, S., Nikolajek, K., Hiller, E., & Toth, B. (2012). Climacteric lowers plasma levels of platelet-derived microparticles: a pilot study in pre- versus postmenopausal women. Acta Haematologica, 128(1), 53–59. · doi:10.1159/000337327
- Green, D. L., & Karpatkin, S. (2009). Effect of cancer on platelets. Cancer Treatment and Research, 148, 17–30. · DOI
- Grignani, G., Pacchiarini, L., Almasio, P., Pagliarino, M., Gamba, G., Rizzo, S. C., et al. (1986). Characterization of the platelet-aggregating activity of cancer cells with different metastatic potential. International Journal of Cancer, 38(2), 237–244. · doi:10.1002/ijc.2910380214
- Pacchiarini, L., Zucchella, M., Milanesi, G., Tacconi, F., Bonomi, E., Canevari, A., et al. (1991). Thromboxane production by platelets during tumor cell-induced platelet activation. Invasion & Metastasis, 11(2), 102–109.
- Tzanakakis, G. N., Krambovitis, E., Tsatsakis, A. M., & Vezeridis, M. P. (2002). The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis. International Journal of Gastrointestinal Cancer, 32(1), 23–30. · DOI
- Gordon, S. G., & Chelladurai, M. (1992). Non-tissue factor procoagulants in cancer cells. Cancer Metastasis Reviews, 11(3–4), 267–282. · DOI
- Kirwan, C. C., McDowell, G., McCollum, C. N., Kumar, S., & Byrne, G. J. (2008). Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. British Journal of Cancer, 99(7), 1000–1006. · doi:10.1038/sj.bjc.6604620
- Starakis, I., Koutras, A., & Mazokopakis, E. E. (2010). Drug-induced thromboembolic events in patients with malignancy. Cardiovascular & Hematological Disorders Drug Targets, 10(2), 94–102. · doi:10.2174/187152910791292493
- Anand, M., & Brat, D. J. (2012). Oncogenic regulation of tissue factor and thrombosis in cancer. Thrombosis Research, 129(Suppl 1), S46–49. · doi:10.1016/s0049-3848(12)70015-4
- Ogiichi, T., Hirashima, Y., Nakamura, S., Endo, S., Kurimoto, M., & Takaku, A. (2000). Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation. Journal of Neuro-Oncology, 46(1), 1–9. · doi:10.1023/a:1006323200001
- Jurasz, P., North, S., Venner, P., & Radomski, M. W. (2003). Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study. Thrombosis Research, 112(1–2), 59–64. · doi:10.1016/j.thromres.2003.10.012
- Lindenmeyer, F., Legrand, Y., & Menashi, S. (1997). Upregulation of MMP-9 expression in MDA-MB231 tumor cells by platelet granular membrane. FEBS Letters, 418(1–2), 19–22. · doi:10.1016/s0014-5793(97)01336-7
- Oleksowicz, L., Mrowiec, Z., Schwartz, E., Khorshidi, M., Dutcher, J. P., & Puszkin, E. (1995). Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells. Thrombosis Research, 79(3), 261–274. · doi:10.1016/0049-3848(95)00113-6
- Timar, J., Trikha, M., Szekeres, K., Bazaz, R., & Honn, K. (1998). Expression and function of the high affinity alphaIIbbeta3 integrin in murine melanoma cells. Clinical & Experimental Metastasis, 16(5), 437–445. · doi:10.1023/a:1006533508560
- Trikha, M., Timar, J., Lundy, S. K., Szekeres, K., Cai, Y., Porter, A. T., et al. (1997). The high affinity alphaIIb beta3 integrin is involved in invasion of human melanoma cells. Cancer Research, 57(12), 2522–2528.
- Iwamura, T., Caffrey, T. C., Kitamura, N., Yamanari, H., Setoguchi, T., & Hollingsworth, M. A. (1997). P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2). Cancer Research, 57(6), 1206–1212.
- Goschnick, M. W., & Jackson, D. E. (2007). Tetraspanins-structural and signalling scaffolds that regulate platelet function. Mini Reviews in Medicinal Chemistry, 7(12), 1248–1254. · doi:10.2174/138955707782795656
- Billroth, T. (1878). Lectures on surgical pathology and therapeutics, a handbook for students and practitioners (vol. II). London: The New Sydenham Society.
- Baserga, R., & Saffiotti, U. (1955). Experimental studies on histogenesis of blood-borne metastases. AMA Archives of Pathology, 59(1), 26–34.
- Chew, E. C., & Wallace, A. C. (1976). Demonstration of fibrin in early stages of experimental metastases. Cancer Research, 36(6), 1904–1909.
- Warren, B. A. (1976). Some aspects of blood borne tumour emboli associated with thrombosis. Zeitschrift für Krebsforschung und Klinische Onkologie. Cancer Research and Clinical Oncology, 87(1), 1–15.
- Oleksowicz, L., & Dutcher, J. P. (1995). Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategies. Medical Oncology, 12(2), 95–102. · doi:10.1007/bf01676709
- Lonsdorf, A. S., Kramer, B. F., Fahrleitner, M., Schonberger, T., Gnerlich, S., Ring, S., et al. (2012). Engagement of alphaIIbbeta3 (GPIIb/IIIa) with alphanubeta3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis. The Journal of Biological Chemistry, 287(3), 2168–2178. · doi:10.1074/jbc.m111.269811
- Beleva, E., & Grudeva-Popova, J. (2013). From Virchow’s triad to metastasis: circulating hemostatic factors as predictors of risk for metastasis in solid tumors. Journal of BUON, 18(1), 25–33.
- Jafari, S., Etminan, M., & Afshar, K. (2009). Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis. Canadian Urological Association Journal, 3(4), 323–330. · DOI
- Chan, A. T., Zauber, A. G., Hsu, M., Breazna, A., Hunter, D. J., Rosenstein, R. B., et al. (2009). Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology. doi: 10.1053/j.gastro.2009.02.045 . · DOI
Cited by
Role of platelets and platelet receptors in cancer metastasis
Schlesinger, M. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0669-2 · Cited by 690
Enzyme-powered Janus platelet cell robots for active and targeted drug delivery
Tang, S., Zhang, F., Gong, H., Wei, F., Zhuang, J., Karshalev, E., Esteban-Fernández de Ávila, B., Huang, C., Zhou, Z., Li, Z., et al. (2020) · Science Robotics · doi:10.1126/scirobotics.aba6137 · Cited by 427
Gonzalez-Avila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., Garcia-Hernandez, A. A., & Falfan-Valencia, R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.02.010 · Cited by 373
Okugawa, Y., Toiyama, Y., Yamamoto, A., Shigemori, T., Ide, S., Kitajima, T., Fujikawa, H., Yasuda, H., Hiro, J., Yoshiyama, S., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003239 · Cited by 280
Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy
Palacios-Acedo, A. L., Mège, D., Crescence, L., Dignat-George, F., Dubois, C., & Panicot-Dubois, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01805 · Cited by 273
Metadata
- Authors
- Menter, D. G., Tucker, S. C., Kopetz, S., Sood, A. K., Crissman, J. D., & Honn, K. V.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2014-03
- Volume
- 33
- Issue
- 1
- Pages
- 231-269
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2079629625
- Cited by
- 316
- References
- 389
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.